SitemapKlarity storyJoin usMedicationServiceAbout us
fsaHSA & FSA accepted; best-value for top quality care
fsaSame-day mental health, weight loss, and primary care appointments available
Excellent
unstarunstarunstarunstarunstar
staredstaredstaredstaredstared
based on 0 reviews
fsaAccept major insurances and cash-pay
fsaHSA & FSA accepted; best-value for top quality care
fsaSame-day mental health, weight loss, and primary care appointments available
Excellent
unstarunstarunstarunstarunstar
staredstaredstaredstaredstared
based on 0 reviews
fsaAccept major insurances and cash-pay
Back

Published: Jul 2, 2026

Share

Telehealth General Psychiatry Prescribing: What Psychiatrists Can Do in Texas

Share

Written by Klarity Editorial Team

Published: Jul 2, 2026

Telehealth General Psychiatry Prescribing: What Psychiatrists Can Do in Texas
Table of contents
Share

If you’re a psychiatrist or PMHNP considering telehealth, you’ve probably asked yourself: Can I actually prescribe medications remotely? What about controlled substances like Adderall or Xanax? Do I need to see patients in person first?

The short answer: Yes, psychiatrists can prescribe medications via telehealth in 2026 — including controlled substances — but the rules vary significantly by state and your provider type. This isn’t about generic telehealth advice with your state’s name slapped on. We’re breaking down the actual regulations, what’s changed recently, and what it means for your practice.

Whether you’re an established psychiatrist looking to add telehealth, a PMHNP navigating collaborative practice requirements, or considering joining a platform like Klarity Health, understanding these prescribing rules is critical to practicing legally and building a sustainable income stream.

The Federal Landscape: DEA Waivers and Ryan Haight Act

Let’s start with the elephant in the room: federal controlled substance prescribing rules.

Before COVID-19, the Ryan Haight Act required an in-person medical evaluation before prescribing controlled substances (Schedule II-V drugs like stimulants, benzodiazepines, or buprenorphine). That made remote ADHD treatment or anxiety management essentially impossible via telehealth.

The pandemic changed everything. The DEA waived that in-person requirement under public health emergency powers, and as of February 2026, those flexibilities remain in effect through December 31, 2025 (with strong indications they’ll be extended further given the mental health access crisis).

What this means practically: You can initiate treatment for ADHD, prescribe Adderall to a new patient you’ve only seen via video, or start someone on Klonopin for panic disorder — all without an initial in-person visit. This is a game-changer for telepsychiatry.

The catch: The DEA has proposed new permanent rules that could require special telemedicine registrations or impose 30-day supply limits for initial prescriptions. These rules haven’t been finalized yet, but you should stay alert to DEA announcements in late 2024. The likely outcome? Some version of the current flexibility will remain for mental health treatment, but with clearer guardrails.

For now, psychiatrists can leverage this window to build telehealth practices that would have been legally impossible five years ago.

Free consultations available with select providers only.

Grow your practice on Klarity

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

Start seeing patients

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

State-by-State Reality: Where Prescribing Authority Actually Lives

Federal law sets the floor, but state law determines your ceiling. And if you’re a PMHNP, state scope-of-practice laws can make or break your ability to practice independently.

Full Practice States vs. Restricted States

As of 2025, approximately 34 states grant Nurse Practitioners Full Practice Authority — meaning PMHNPs can evaluate, diagnose, and prescribe independently without physician oversight. But if you’re licensed in Texas, Florida, or Pennsylvania, you’re operating under different rules entirely.

For Psychiatrists (MD/DO): You have unrestricted prescribing authority in all 50 states. Your only constraints are federal DEA rules and any state-specific telehealth requirements (like checking prescription monitoring databases).

For PMHNPs: Your authority depends entirely on where your patient is located:

  • Full Practice States (e.g., Washington, Oregon, Colorado, Arizona): You can practice independently after initial certification. No physician collaboration required.
  • Transitional States (e.g., New York, Illinois, California): You need physician collaboration initially, but can become independent after meeting experience requirements (typically 2-4 years).
  • Restricted States (e.g., Texas, Florida, Pennsylvania): You need ongoing physician oversight indefinitely — no pathway to independence.

Let’s dig into what this looks like in the states where most telepsychiatry happens.

California: The Transition to Independence

For Psychiatrists: Full prescribing authority. You can conduct telehealth evaluations and prescribe any psychiatric medication, including controlled substances, as long as you perform a ‘good faith exam’ (video counts).

For PMHNPs: California is mid-transition thanks to AB 890 (2020). Here’s the timeline:

  • Before 2023: All NPs needed physician-supervised ‘standardized procedures’ to prescribe
  • January 2023: NPs with ≥3 years experience can become ‘103 NPs’ — practicing in group settings without direct supervision (though with physicians available)
  • January 2026: Those experienced NPs can apply for ‘104 NP’ status — full independent practice, including solo private practice

What this means: If you’re a new grad PMHNP in California, you’ll need a supervising psychiatrist for your first three years. After that, you can apply for increasing levels of autonomy. By 2026, experienced California PMHNPs will functionally have the same prescribing authority as psychiatrists.

Key compliance requirement: All prescribers must check California’s CURES database (prescription drug monitoring program) before prescribing Schedule II-IV controlled substances.

Reimbursement: California law requires private insurers to reimburse telehealth at parity with in-person visits — you won’t take a pay cut for seeing patients remotely.

Texas: Physician Oversight Required

For Psychiatrists: Full authority. Texas allows telemedicine prescribing if the standard of care is met via real-time audio-visual communication. The only restriction: you cannot prescribe Schedule II opioids for chronic pain management via telehealth (not relevant for most psychiatric practice).

For PMHNPs: Texas is one of the most restrictive states. You must have a Prescriptive Authority Agreement with a Texas-licensed physician to prescribe anything — including non-controlled medications.

Key Texas requirements:

  • The supervising physician can oversee a maximum of 7 NPs/PAs at once
  • Monthly face-to-face meetings required for the first 3 years, then quarterly
  • NPs generally cannot prescribe Schedule II controlled substances in outpatient settings (with very limited exceptions for pediatric ADHD treatment under specific protocols)
  • Your agreement must explicitly authorize which medications you can prescribe

Reality check: If you’re a PMHNP in Texas doing telehealth ADHD treatment, the psychiatrist will likely need to write the initial stimulant prescription, and you’ll manage refills of Schedule III-V medications under delegation. This is why many Texas PMHNPs work for platforms that provide supervising physicians rather than trying to negotiate individual collaboration agreements.

For psychiatrists: This creates opportunity. Texas has some of the worst psychiatrist shortages in the nation (1 psychiatrist per ~8,500 residents), and supervising NPs can generate additional revenue streams while expanding patient access.

Florida: Psychiatric Carve-Out

For Psychiatrists: Full authority, with a notable advantage — Florida explicitly allows controlled substance prescribing via telehealth for psychiatric treatment (Florida Statutes 456.47). This is more permissive than many states.

For PMHNPs: Complicated. Florida passed HB 607 (2020) creating ‘Autonomous APRN’ status, but psychiatric NPs were excluded. Only primary care NPs (family medicine, general internal medicine, pediatrics) can practice independently.

PMHNPs in Florida must:

  • Practice under a supervising physician’s protocol
  • Have a psychiatrist as their collaborating physician (not just any physician) to prescribe psychotropic controlled substances
  • Follow a 7-day limit on Schedule II prescriptions — except ‘psychiatric nurses’ treating mental health conditions are exempt from this limit

What ‘psychiatric nurse’ means: A PMHNP with an MSN/DNP in psychiatric nursing and ≥2 years post-graduate experience under a psychiatrist. This designation allows broader prescribing authority for mental health treatment, but still requires collaboration.

The political landscape: Bills to extend autonomous practice to psychiatric NPs (like 2024’s HB 771) have been introduced but haven’t passed. Until that changes, Florida PMHNPs need physician oversight.

Upside: Florida’s explicit telehealth-friendly law for psychiatric prescribing makes it an attractive state for telepsychiatry expansion — if you can navigate the NP supervision requirements.

New York: Path to Independence

For Psychiatrists: Full authority. New York recently finalized regulations (mid-2025) explicitly allowing controlled substance prescribing via telehealth when consistent with federal DEA waivers — removing prior state-level obstacles.

For PMHNPs: New York offers a transition to independence model that works well in practice:

  • First 3,600 hours (~2 years): Practice under a written collaborative agreement with a physician (usually a psychiatrist). The agreement outlines protocols, but New York doesn’t mandate specific chart review frequencies or meetings.
  • After 3,600 hours: File an attestation with the state and drop the written agreement. You practice independently with only an informal ‘collaborative relationship’ (meaning you have physician contacts for referrals, but no supervision).

Bottom line: Experienced New York PMHNPs effectively have full practice authority. This has led to many opening solo practices, especially in underserved upstate regions.

Important: New York requires e-prescribing for all controlled substances (no paper scripts) and mandates checking the I-STOP PMP registry before prescribing Schedule II-IV drugs.

Pennsylvania: Still Waiting for Reform

For Psychiatrists: Full authority.

For PMHNPs: Pennsylvania requires a collaborative agreement indefinitely — no pathway to independence yet, despite neighboring states granting it.

Requirements:

  • Written collaboration agreement filed with the State Board of Nursing
  • Agreement must specify prescribing scope (including which controlled substances)
  • Schedule II prescriptions limited to 30-day supply; physician must be notified within 24 hours
  • Physician must review a percentage of NP charts (typically 10% quarterly, though specifics vary by practice)

Legislative outlook: Full Practice Authority bills have passed the Pennsylvania Senate but stalled in the House. Given the trend in surrounding states (New York, Ohio, Maryland all granted FPA recently), Pennsylvania may follow in the next 1-2 years.

For now: Pennsylvania PMHNPs need to secure collaborating physicians, which can be costly and logistically challenging. Many work for health systems or telehealth companies that provide this infrastructure.

Illinois: Transition Period with Clear Path Forward

For Psychiatrists: Full authority.

For PMHNPs: Illinois requires 4,000 hours of practice under a collaborative agreement (≈2 years) plus 250 hours of continuing education in advanced pharmacology. After meeting these requirements, you can apply for ‘Illinois Full Practice Authority’ and practice independently.

Until you get FPA:

  • Practice under a written collaborative agreement
  • Your prescriptions must list the collaborating physician’s name
  • Controlled substance prescribing follows delegated authority rules

After FPA:

  • Prescribe independently, including controlled substances (you’ll need a mid-level practitioner controlled substance license)
  • Operate your own practice without supervision

Unique note: Illinois law restricts even FPA NPs from prescribing opioids for chronic pain management without physician consultation — but this rarely affects psychiatric practice.

Reimbursement advantage: Illinois law (SB 667, 2021) mandates equal reimbursement for telehealth services through at least 2027, meaning you won’t face pay cuts for remote work.

What About Prescribing Across State Lines?

This trips up many providers. You must be licensed in the state where the patient is physically located at the time of the telehealth visit. Period.

The Interstate Medical Licensure Compact (IMLC) helps expedite getting licenses in member states. Among our priority states:

  • Texas, Pennsylvania, and Illinois are IMLC members
  • New York, Florida, and California are not (you’ll need traditional licensure)

For PMHNPs: Some states have joined the APRN Compact, but this does not override scope-of-practice laws. A compact license just means one license is recognized in multiple states — you still must follow each state’s collaboration requirements.

Practical example: If you’re a California PMHNP with a compact license seeing a patient in Texas via telehealth, you must follow Texas rules — meaning you need a Texas physician collaboration agreement, even though you can practice independently in California.

This is why many telepsychiatry platforms handle multi-state licensure and collaboration agreements on behalf of providers. Doing it solo gets expensive and complex quickly.

Reimbursement Reality: What You’ll Actually Get Paid

Let’s talk numbers, because prescribing authority means nothing if you can’t build a sustainable practice.

Medicare Rates (2026 National Averages)

  • Initial psychiatric evaluation (90792): ~$173
  • 15-minute med check (99213): ~$95
  • 25-minute med check (99214): ~$136
  • 40-minute complex visit (99215): ~$192

For PMHNPs: Medicare pays 85% of physician rates when you bill under your own NPI. So that 99213 becomes ~$81 instead of $95.

Telehealth parity: Medicare permanently covers telehealth for mental health services at the same rates as in-person (with a minor requirement of one in-person visit every 12 months, currently paused).

Private Insurance

Commercial rates typically exceed Medicare by 20-60% depending on region and insurer. In high-cost areas like San Francisco or New York City, a 99214 might pay $200-250 from a major insurer.

State parity laws matter here. States like California, Illinois, and New York mandate equal reimbursement for telehealth, while others leave it to contract negotiations.

Medicaid

Generally pays less than Medicare — often 60-80% of Medicare rates — but volume can be high due to extensive unmet need. Many state Medicaids have enhanced behavioral health reimbursement or case management fees that supplement visit payments.

Cash Pay and Hybrid Models

Many telepsychiatry providers use hybrid models:

  • Charge $150-250 per session self-pay for patients who prefer to avoid insurance
  • Accept insurance for initial evaluations to reduce patient acquisition barriers
  • Use ‘superbills’ for out-of-network reimbursement

Reality check on patient acquisition costs: Acquiring a qualified psychiatric patient through DIY marketing (Google Ads, SEO, directories) typically costs $200-500+ when you account for:

  • Ad spend (mental health keywords run $15-40 per click)
  • Agency/consultant fees
  • Staff time qualifying leads
  • No-show rates from cold leads
  • Months of SEO investment before results

Psychology Today and Zocdoc charge monthly fees ($30-100+) AND you compete with hundreds of other providers. Zocdoc adds per-booking fees ($35-100).

Platforms like Klarity use a pay-per-appointment model: instead of gambling $3,000-5,000/month on marketing with uncertain results, you pay a standard listing fee only when a pre-qualified patient books with you. That’s guaranteed ROI — you only pay when you actually see a patient, and they handle the marketing, patient matching, and telehealth infrastructure.

Compliance Essentials: How to Prescribe Legally

Regardless of your state, follow these practices to stay compliant:

1. Establish a Valid Patient-Physician Relationship

Conduct a thorough evaluation via secure video (audio-only typically doesn’t suffice for initial controlled substance prescribing, though follow-ups may be acceptable in some states). Document the encounter with the same detail as an in-person visit.

2. Check Prescription Drug Monitoring Programs (PDMPs)

Every state requires checking the PDMP before prescribing controlled substances:

  • California: CURES
  • Texas: Texas PMP
  • Florida: E-FORCSE
  • New York: I-STOP
  • Pennsylvania: PA PDMP
  • Illinois: Illinois PMP

Many states mandate checking before the first prescription and periodically thereafter (e.g., California requires checking at least every 4 months for ongoing therapy).

3. Use E-Prescribing

Some states (New York, for example) require electronic prescribing for all controlled substances. Even where not mandated, e-prescribing reduces errors and diversion risk.

4. Document Telehealth-Specific Elements

  • Technology used (video platform)
  • Patient’s location and consent for telehealth
  • Emergency plan if patient is in crisis
  • Rationale for controlled substance prescribing when applicable

5. Maintain Appropriate Licensure

  • Active license in the state where patient is located
  • Active DEA registration (includes state of practice)
  • For NPs: Current collaborative agreements where required, filed with appropriate boards

6. Stay Updated on DEA Rule Changes

The permanent controlled substance teleprescribing rules will likely be finalized in late 2024. Subscribe to DEA updates and professional association newsletters (APA, AAPP, state nursing boards).

The Business Case for Telepsychiatry Prescribing

Understanding the rules is one thing. Building a practice around them is another.

Why telehealth medication management works economically:

  1. Reduced overhead: No office lease, minimal front-desk staff
  2. Geographic flexibility: See patients across multiple states (with proper licensure)
  3. Better scheduling efficiency: Back-to-back video appointments with no patient transit time
  4. Lower no-show rates: Telehealth no-show rates typically run 10-15% vs. 20-30% for in-office
  5. Access to underserved markets: Rural patients and those in provider shortage areas will pay premium rates or drive high insurance volume

The provider shortage is real:

  • Texas needs ~614 additional psychiatrists to eliminate Health Professional Shortage Areas
  • Florida needs ~424
  • California has over 11 million residents in mental health HPSAs
  • Even well-served states like New York have 197 shortage areas needing ~230 psychiatrists

This scarcity = pricing power. Psychiatric medication management is one of the few medical specialties where providers can consistently maintain 90%+ panel capacity.

Platform vs. Solo Practice: The Economics

Solo telehealth practice gives you maximum control and (eventually) the best per-visit margins. But it requires:

  • $3,000-5,000/month in marketing spend (minimum) with 6-12 months before ROI
  • EHR and telehealth platform costs ($200-500/month)
  • Billing and credentialing staff or services (15-20% of collections)
  • Multi-state licensure costs ($500-1,500 per state, annually)
  • Time managing all the above instead of seeing patients

Platform model (like Klarity Health):

  • Zero upfront marketing spend
  • Pre-qualified patients matched to your availability and specialty
  • Built-in telehealth and EHR infrastructure
  • Handle multi-state credentialing and compliance
  • You pay per appointment (percentage or flat fee per patient)

Do the math: If you’re paying 30% per appointment to a platform but they deliver 20-30 patients per week with zero marketing spend on your end, you’re netting more than spending $4,000/month on ads that might deliver 5-10 patients.

Especially for providers starting telehealth or scaling up, the platform model removes risk entirely. You can always transition to independence once you’ve built a reputation and patient base.

FAQ

Can I prescribe Adderall via telehealth in 2026?
Yes, under current federal DEA waivers (extended through December 31, 2025), psychiatrists can prescribe Schedule II stimulants like Adderall to new patients via video visit without an initial in-person exam. Stay alert to DEA rule changes in late 2024, but mental health treatment is likely to retain this flexibility.

Do PMHNPs have the same prescribing authority as psychiatrists?
It depends entirely on the state. In Full Practice Authority states (34+ states), experienced PMHNPs can prescribe independently including controlled substances. In restricted states like Texas, Florida, and Pennsylvania, PMHNPs need physician oversight and may face additional controlled substance limitations.

Can I prescribe across state lines via telehealth?
Only if you hold an active license in the state where the patient is located at the time of the appointment. You cannot treat a Florida patient with only a California license, even via video.

What’s the reimbursement difference between psychiatrists and PMHNPs?
Medicare pays PMHNPs 85% of physician rates. Some private insurers pay PMHNPs equally, others follow Medicare’s 85% model. A few states mandate equal reimbursement by law.

Do I need to check the prescription monitoring database every time?
Yes, when prescribing controlled substances. Most states require checking before the initial prescription and periodically (e.g., every 90-180 days for ongoing patients). Specific requirements vary by state.

Can I do audio-only appointments for medication management?
For follow-up visits in some circumstances, yes — Medicare and some states now reimburse audio-only mental health visits. However, initial controlled substance prescriptions typically require video evaluation to meet standard-of-care requirements.

What happens if the federal telehealth flexibilities expire?
Congress and the DEA have consistently extended these flexibilities, recognizing the mental health access crisis. Most experts anticipate permanent rules will preserve telehealth prescribing for mental health treatment, possibly with minor requirements like 30-day initial supply limits or annual in-person visits.

Take the Next Step

If you’re a psychiatrist or PMHNP ready to leverage telehealth, understanding these prescribing rules is just the foundation. The real question is: how do you build a practice that’s both legally compliant and financially sustainable?

Klarity Health offers providers:

  • Pre-qualified patient flow (both insurance and cash-pay)
  • Compliance infrastructure across all 50 states
  • No upfront marketing costs — pay only per completed appointment
  • Full telehealth platform with integrated EHR
  • Support for multi-state licensure and credentialing

Instead of spending months and thousands of dollars testing marketing channels, you can start seeing patients immediately with guaranteed ROI.

Explore joining Klarity’s provider network and see how telepsychiatry prescribing can expand your practice without the risk.


Sources and References

Source & URLType of SourcePublished/UpdatedReliability
California Board of Registered Nursing – AB 890 FAQs (www.rn.ca.gov)Official state regulatory board websiteUpdated Nov 2023High – Primary source on CA NP scope implementation
Texas Board of Nursing – APRN Practice FAQ (www.bon.texas.gov)Official state board FAQRevised 2021High – Primary for TX NP rules
Zivian Health ‘2026 NP-Physician Collaboration Roadmap’ (www.zivianhealth.com)Industry compliance blogFeb 16, 2026Medium – Detailed overview aligning with state statutes
NursePractitionerLicense.com – Illinois NP limitations (www.nursepractitionerlicense.com)Educational portalUpdated Feb 12, 2024Medium – Consolidates state law accurately
JDSupra Law News – NY NP Independence Article (www.jdsupra.com)Law firm articleApril 13, 2022High – Cites NY Education Law changes
Florida Statutes Chapter 464 & 456 (www.flsenate.gov)Official state statutes2024 compilationHigh – Primary legal text
Pennsylvania Coalition of Nurse Practitioners (www.pacnp.org)Professional associationUpdated 2022Medium – Accurate reflection of PA law
NursePractitionerOnline.com – NP Practice Authority 2026 (www.nursepractitioneronline.com)Professional articleLast verified Feb 5, 2026Medium – Provides overall trends
Center for Connected Health Policy – Texas Telehealth Laws (www.cchpca.org)Non-profit policy databaseUpdated Jan 19, 2026High – Comprehensive state-by-state telehealth regulations
National Law Review – Telehealth Prescribing Update (natlawreview.com)Legal newsAug 15, 2025High – Analysis by healthcare attorneys
Nixon Peabody Client Alert – NY telemedicine rule (www.nixonpeabody.com)Law firm client alertJune 18, 2025High – Expert interpretation of NYSDOH rule
Texas Nurse Practitioners Assoc. – DEA Extension (texasnp.org)Professional association newsOct 6, 2023High – Cites DEA announcements
TheraThink – Insurance Reimbursement Rates 2026 (therathink.com)Medical billing service blog2026 ratesMedium – Uses CMS data for Medicare rates
Healing Psychiatry Florida – Psychiatrist Shortage by State (www.healingpsychiatryflorida.com)Healthcare blogJan 15, 2026Medium – Data-driven, quotes HRSA stats
Texas Capitol – SB 406 Analysis (capitol.texas.gov)State legislative analysis2013 (83rd session)High – Primary source for TX supervision limits

Source:

Get expert care from top-rated providers

Find the right provider for your needs — select your state to find expert care near you.

Related posts

logo
All professional services are provided by independent private practices via the Klarity technology platform. Klarity Health, Inc. does not provide medical services.
Phone:
(866) 391-3314

— Monday to Friday, 7:00 AM to 4:00 PM PST

Mailing Address:
1825 South Grant St, Suite 200, San Mateo, CA 94402

Join our mailing list for exclusive healthcare updates and tips.

Stay connected to receive the latest about special offers and health tips. By subscribing, you agree to our Terms & Conditions and Privacy Policy.
logo
All professional services are provided by independent private practices via the Klarity technology platform. Klarity Health, Inc. does not provide medical services.
Phone:
(866) 391-3314

— Monday to Friday, 7:00 AM to 4:00 PM PST

Mailing Address:
1825 South Grant St, Suite 200, San Mateo, CA 94402
If you’re having an emergency or in emotional distress, here are some resources for immediate help: Emergency: Call 911. National Suicide Prevention Lifeline: call or text 988. Crisis Text Line: Text HOME to 741741.
HIPAA
© 2026 Klarity Health, Inc. All rights reserved.